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Abstract: Ischemic postconditioning refers to several transient reperfusion and ischemia 
cycles after an ischemic event and before a long duration of reperfusion. The procedure 
produces neuroprotective effects. The mechanisms underlying these neuroprotective effects 
are poorly understood. In this study, we found that most neurons in the CA1 region died 
after 10 minutes of ischemia and is followed by 72 hours of reperfusion. However, brain 
ischemic postconditioning (six cycles of 10 s/10 s reperfusion/re-occlusion) signiﬁcantly 
reduced neuronal death. Signiﬁcant up-regulation of Glutamate transporter-1 was found 
after  3,  6,  24,  72  hours  of  reperfusion.  The  present  study  showed  that  ischemic 
postconditioning decreases cell death and that upregulation of GLT-1 expression may play 
an important role on this effect. 
Keywords: ischemic postconditioning; brain ischemia reperfusion injury; neuroprotection;  
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1. Introduction  
Ischemic stroke is a leading cause of mortality and adult morbidity in humans. Extensive research 
has been conducted to find drugs that reduce injury following brain ischemia/reperfusion; however, no 
effective neuroprotective drugs have been found for use in clinical practice [1]. 
Ischemic  postconditioning  refers  to  several  transient  reperfusion  and  ischemia  cycles  after  an 
ischemic event and before a long duration of reperfusion. Its cerebral protective effects have been 
proven in different animal models [2–5], but its mechanism has not been clarified. 
Glutamate is one of the main neurotransmitters and works at a variety of excitatory synapses in the 
nervous system [6]. However, it is also believed to lead to glutamate excitotoxicity—an important 
mechanism  of  cell  death  induced  by  ischemic  insult  [7].  Many  studies  have  proven  that  the 
extracellular concentration of glutamate is elevated to levels leading to neuronal death in ischemia.  
Glutamate transporters are essential for maintaining low concentration by removing the glutamate 
from the extracellular space. At present, five glutamate transporters have been identified in the rat 
brain. These glutamate transporters, are GLAST, GLT-1, EAAT3, EAAT4 and EAAT5 [8]. 
Glutamate transporter-1 (GLT-1), which is the most abundant glutamate transporter in brain, plays a 
principal role in keeping the glutamate concentration low by removing the glutamate released at the 
synapse  [9].  In  view  of  the  importance  of  GLT-1  in  the  maintenance  of  appropriate  glutamate 
concentrations, it is reasonable to infer that GLT-1 is involved in the protective effect of brain ischemic 
postconditioning. However, there have been no reports regarding the role of GLT-1 in brain ischemic 
tolerance generated by ischemic postconditioning. 
In this study, we tested the hypothesis that ischemic postconditioning reduces neuronal death by 
upregulating GLT-1. We used the 4-vessel occlusion (4-VO) animal model, Hematoxylin/erosin and 
cresyl  violet  staining  were  used  to  elucidate  the  protective  effect  of  postconditioning  in  the 
hippocampal CA1 at 72 hours after reperfusion and hippocampal GLT-1 expression was measured  
at  3,  6,  24,  72  hours  of  reperfusion  to  demonstrate  the  neuronal  protective  mechanism  of  
ischemic postconditioning.  
2. Results and Discussion  
2.1. Neuropathological Evaluation of Hippocampal CA1 by Hematoxylin/Erosin Staining 
The distribution of pyramidal cells in CA1 was examined 72 hours after reperfusion. As shown in 
Figure 1, in the sham group, pyramidal neurons were layered and in regular arrangements with large, 
round, transparent, and intact nuclei (Figure 1A, 1B). In the I/R group, the neurons in the CA1 region 
were  severely  damaged,  in  disorderly  arrays,  significantly  reduced  in  number,  and  characterized  
by  pyknotic  and  indistinct  nuclei  (Figure  1C,  1D).  Six  cycles  of  10-second/10-second  of  
reperfusion/re-occlusion significantly decreased cell death in CA1 (Figure 1E, 1F).  Int. J. Mol. Sci. 2010, 11                       
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Figure  1. Neuropathological evaluation of hippocampal CA1 by hematoxylin and eosin 
staining. Representative photomicrographs in the hippocampal region (× 40) (A, C, E) and 
hippocampus CA1 (× 400) (B, D, F).  
 
2.2. Neuron Counts in Hippocampal CA1, as Determined by Cresyl Violet Staining 
We used the cell density to assess the effect of ischemic postconditioning in the hippocampal CA1 
region by using cresyl violet staining (Figure 2). In the sham group, pyramidal cells displayed round, 
pale, stained nuclei. We observed that 72 hours after re-perfusion, most CA1 pyramidal cells were 
destroyed in I/R group. The number of surviving neurons increased significantly in the I PostC group 
as compared to the I/R group (P < 0.01). The numbers of surviving pyramidal cells in the hippocampal 
CA1 region of the I/R and I PostC groups, respectively, were ~23.5% and ~62.8% percent of those 
observed in rats treated with the sham operation (Figure 3)． Int. J. Mol. Sci. 2010, 11                       
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Figure 2. Neuroprotective effect of ischemic postconditioning on neuron death induced by 
global ischemia/reperfusion in the hippocampal CA1, as determined using cresyl violet 
staining.  A,  D:  sham  group;  B,  E:  ischemia/reperfusion  group;  C,  F:  Ischemic 
postconditioning group. Magnification, (× 40) (A, B, C) and (× 400) (D, E, F). 
 
Figure 3. Histogram representing numbers of surviving neurons in CA1/mm after 72 hours 
of reperfusion (n = 4). *: I/R group versus Sham group (P < 0.01). #: I PostC group versus 
I/R group (P < 0.01). 
 
2.3. Expression of GLT-1  
Western blot analysis was carried out to identify the expression of GLT-1 at the protein level in the 
hippocampus (Figure 4). The fact that GLT-1 was expressed in sham-treated animals indicated its 
presence in the normal rat hippocampus. At each designated time point after reperfusion, the amount of 
GLT-1 in both the I/R and I PostC groups increased significantly as compared with that of the sham Int. J. Mol. Sci. 2010, 11                       
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group (P < 0.01). We observed an increase in GLT-1 protein in the I PostC group as compared with the 
I/R group at 3 hours, 6 hours, 24 hours and 72 hours after reperfusion, respectively. (P < 0.05). 
Figure  4.  Expression  of  GLT-1  protein  at  3,  6,  24  and  72  hours  after  reperfusion. 
Hippocampus in the sham group, I/R group and I PostC group. *: GLT-1 of I/R group 
increased significantly as compared with that of the sham group (P < 0.01). #: I PostC 
group  had  greater  upregulation  of  GLT-1  compared  to  the  I/R  group  at  every  time 
point (P < 0.05). 
 
2.4. Discussion 
Our study demonstrated that after six cycles of 10 s/10 s ischemic postconditioning administered to 
global cerebral ischemic rats followed with reperfusion for 72 hours, the extent of neuronal cell loss 
was  decreased  significantly  in  the  ischemic  injury-prone  hippocampal  CA1  region.  This  finding 
suggests that ischemic postconditioning can protect neurons. We found that ischemic postconditioning 
can  increase  the  GLT-1  level  in  hippocampus.  This  may  be  one  of  the  mechanisms  of  ischemic 
postconditioning. Due to the upregulation of GLT-1, it is possible to decrease glutamate accumulation 
in the synaptic cleft and thereby reduce the overactivation of postsynaptic glutamate receptors, thus 
attenuating the death of neurons. 
Ischemic  postconditioning  (I  PostC)  is  carried  out  by  administering  several  cycles  of  short 
reperfusion/ischemia at  the early stage of reperfusion. Many researchers have proven that  I PostC 
protects the brain and have been trying to study the mechanism from different perspectives. Using  
4-VO global cerebral ischemic rats, Wang  et al. found that I PostC can reduce neuronal death in 
hippocampus and increase the spatial memory of rats. This may be related to I PostC’s ability to 
improve disturbed cerebral blood flow and inhibit the release of cytochrome c [3]. Using MCAO rats, Int. J. Mol. Sci. 2010, 11                       
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Xing et al. found that I PostC can reduce infarct size, increase neurologic score, upregulate Bcl-2 and 
Hsp70, and inhibit caspase-3, Bax and cytochrome c. The authors speculated that brain protection by 
I PostC may be due to inhibition of cell apoptosis [2]. Gao et al. found that the effects of I PostC are 
related to changes in the Akt, MAPK and PKC signaling pathways [10,11].  
The excitotoxicity of glutamate is considered to be an important reason for neuronal death after 
ischemia [12–14]. Therefore, reducing the amount of glutamate in extracellular fluid during ischemia 
would  lessen  the  damage  to  neurons.  Glutamate  is  reabsorbed  mainly  by  glutamate  transporters. 
Although  neurons  express  glutamate  transporter,  it  is  usually  believed  that  glutamate  transporters, 
especially GLT-1, play the dominant role in maintaining extracellular glutamate level [9,15]. 
GLT-1  could  be  involved  in  many  neuropathic  processes.  For  example,  in  studies  on  cerebral 
ischemia, some authors have presumed that the decrease of GLT-1 is the reason for increases in the 
level of glutamate [16–19]. In other studies, it was found that levels of glutamate transporter increased 
after  ischemia.  The  authors  considered  this  as  a  compensatory  response  to  increased  glutamate 
reabsorbed under these conditions [20,21]. In addition, it has been shown that GLT-1 is also involved 
in  pathological  processes  such  as  brain  trauma,  neurodegenerative  disease  and  epilepsy  [22–25]. 
Namura et al. found that downregulation of GLT-1 can enhance brain edema after ischemia [26]. Our 
previous work showed that GLT-1 may play a role in ischemia-related epilepsy [27]. 
The role of GLT-1 in I PostC has not yet been studied. In this study, we found that hippocampal 
GLT-1 in I/R group increased compared to the sham group. After I PostC, a further increase of GLT-1 
was found. Thus, we speculate that the upregulation of GLT-1 may be a self-protection mechanism 
after cerebral ischemia; I PostC can enhance the protective effect, thereby reducing neuronal damage. 
3. Experimental Section  
3.1. Animal Groups 
All animal protocols were approved by the School of Medicine Animal Care and Use Committee of 
Shanghai Jiao Tong University. Eighty-four adult male Sprague-Dawley rats (220–250 g) were used for 
this study. The rats were randomly assigned to three groups: sham (Sham) group (3 hours, n = 6; 
6 hours, n = 6; 24 hours, n = 6; 72 hours, n = 10); ischemia/reperfusion (I/R) group (3 hours, n=6; 
6 hours, n = 6; 24 hours, n = 6; 72 hours, n = 10) and ischemic postconditioning (I PostC) group 
(3 hours,  n  = 6;  6 hours, n = 6;  24 hours, n = 6;  72 hours, n = 10). Animals  were housed in  a 
12 hours/12 hours light/dark cycle environment with free access to water and food.  
3.2. Animal Model and Surgical Procedure 
The 4-vessel occlusion (4-VO) animal model, which we have described previously, was used to 
establish global brain ischemia [28]. In brief, rats were anesthetized by intraperitoneal administration 
of 20% chloral hydrate (350 mg/kg). Both vertebral arteries were electrocauterized and the bilateral 
common carotid arteries were separated on day 1. On the following day, the bilateral common carotid 
arteries were clamped with aneurysm clips for 10 minutes to cause global brain ischemia. Rats that  
had  lost  the  righting  reflex,  had  dilated  pupils,  and  were  unresponsive  to  light,  were  used  in  
the experiments. Int. J. Mol. Sci. 2010, 11                       
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In the sham group, rats were anesthetized, both vertebral arteries were electrocauterized and the 
bilateral common carotid arteries were separated, but not occluded. In the ischemia/reperfusion group, 
rats were subjected to 10 minutes of global ischemia and then the aneurysm clip was loosened to 
permit reperfusion. In the ischemic postconditioning group, rats were subjected to 10 minutes of global 
ischemia, which was followed by ischemic postconditioning.  
The ischemic postconditioning protocol was as follows: rats in the I PostC group were subjected to 
six cycles of 10 seconds of reperfusion and 10 seconds of ischemia by removing aneurysm clips and 
then occluding the clips (Figure 5). 
Figure 5. Experimental protocol used to determine the effects of ischemic postconditioning 
(I  PostC)  after  ischemia/reperfusion.  Sham:  sham-operated  rats,  rats  were  anesthetized, 
both  vertebral  arteries  were  electrocauterized  and the bilateral  common carotid  arteries 
were separated, but not occluded; I/R: rats subjected to 10 minutes of 4-vessel occlusion  
(4-VO) followed by reperfusion; I PostC, rats treated with ischemic postconditioning after 
10 minutes of 4-VO by six cycles of 10 s/10 s reperfusion/ischemia (at the beginning of 
reperfusion). Reperfusion lasted for 3, 6, 24 or 72 hours. 
 
3.3. Histological Assessment 
At 72 hours after reperfusion, rats (n = 4 in each group) were deeply anesthetized with chloral 
hydrate and perfused with normal saline, followed by perfusion with 4% paraformaldehyde. The brains 
were quickly removed and postfixed in 4% paraformaldehyde for 24 hours. The postfixed brains were 
embedded in paraffin. Coronal sections 5 μm thick were cut with a microtome. The sections were 
stained with Hematoxylin/erosin and cresyl violet, and examined with a light microscope. The cell 
density among hippocampal CA1, which was expressed as the ratio of survive cells per 1 mm length in 
CA1 as counted under a light microscope, was used to assess the extent of brain damage. Int. J. Mol. Sci. 2010, 11                       
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3.4. Western Blotting 
Western blotting was used to measure levels of GLT-1 protein in each animal in each group at all 
time  points  examined  (3,  6,  24,  and  72  hours  after  reperfusion;  n  =  6).  The  hippocampus  was 
homogenized for 30 min at 4 °C  with an ultrasonic wave in 200 mL of an RIPA lysis buffer containing: 
50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton x-100, 1% Sodium Deoxycholate, 
0.1% SDS, add 1 mM PMSF and proteintase inhibitor cocktail. The homogenates were then lysed in 
SDS buffer. Protein concentration was determined using the Bio-Rad Protein Assay Kit and the sample 
(20  μg)  was  separated  on  Tris-glycine  gel,  then  transferred  to  a  nitrocellulose  membrane,  and 
immunoblotted. Blots were probed with rabbit polyclonal anti-GLT-1 (1:1000; Abcam). The blot was 
then incubated with IRDye 800CW goat anti-mouse secondary antibody (1:4000, LI-COR Biosciences, 
Lincoln, NE, U.S.) and bound antibodies were detected using the LI-COR imaging system. The blots 
were  stripped  and  reprobed  with  mouse  anti-tubulin  (1:1000;  Sigma)  as  a  loading  control.  The 
experiments  were  repeated  three  times  to  obtain  an  average  value.  The  band  density  values  were 
calculated as a ratio of GLT-1/tublin. 
3.5. Statistical Analysis  
Data are presented as mean ±  SEM. Data analysis was performed using SAS software. Statistical 
significance was determined by one-way ANOVA with a Newman-Keuls post test for neuron counting. 
Western blot analysis was performed using two-way analysis of variance (ANOVA) followed by the 
Student-Newman-Keuls test. Values were considered to be significant when P < 0.05. 
4. Conclusions  
Our study is the first to demonstrate that GLT-1 levels increased after ischemic postconditioning, 
which helps to further demonstrate the protective effect of I PostC on brain. 
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